Get the Stockscreener App
55.48
3.12%
1.68
Phibro Animal Health Corp stock is traded at $55.48, with a volume of 322.26K.
It is up +3.12% in the last 24 hours and up +7.81% over the past month.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
See More
Previous Close:
$53.80
Open:
$52.98
24h Volume:
322.26K
Relative Volume:
1.18
Market Cap:
$2.25B
Revenue:
$1.46B
Net Income/Loss:
$92.09M
P/E Ratio:
24.60
EPS:
2.2555
Net Cash Flow:
$47.29M
1W Performance:
+5.66%
1M Performance:
+7.81%
6M Performance:
+45.05%
1Y Performance:
+151.50%
1-Day Range:
$52.41
$55.67
1-Week Range:
$49.89
$55.67
52-Week Range:
$16.16
$56.30
Phibro Animal Health Corp Stock (PAHC) Company Profile
Name
Phibro Animal Health Corp
Sector
Phone
201-329-7300
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
55.48 | 2.25B | 1.46B | 92.09M | 47.29M | 2.2555 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-16-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-10-24 | Initiated | JP Morgan | Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Underperform |
| Dec-21-22 | Initiated | ROTH Capital | Buy |
| Jul-25-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-10-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Nov-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-07-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Aug-06-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Feb-06-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Jan-28-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-05-19 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Aug-29-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-11-19 | Initiated | Barclays | Underweight |
| May-23-19 | Initiated | Guggenheim | Neutral |
| May-09-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-23-17 | Resumed | BofA/Merrill | Underperform |
| Jun-02-17 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-15-16 | Initiated | Piper Jaffray | Overweight |
| Nov-11-16 | Downgrade | Macquarie | Neutral → Underperform |
| Nov-10-16 | Downgrade | Gabelli & Co | Buy → Hold |
| Apr-11-16 | Reiterated | Guggenheim | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Jan-15-16 | Downgrade | Barclays | Overweight → Underweight |
| Sep-30-15 | Initiated | Gabelli & Co | Buy |
| Apr-24-15 | Reiterated | Barclays | Overweight |
| Apr-21-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-06-14 | Initiated | Barclays | Overweight |
View All
Phibro Animal Health Corp Stock (PAHC) Latest News
TerrAscend (OTCMKTS:TSNDF) and Phibro Animal Health (NASDAQ:PAHC) Head to Head Analysis - Defense World
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells $272,764.80 in Stock - Defense World
Is It Too Late To Consider Phibro Animal Health (PAHC) After Its 143% One Year Surge? - Yahoo Finance
PAHC Earnings History & Surprises | EPS & Revenue Results | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
BFI Co sells Phibro Animal Health (PAHC) stock worth $1.19 million By Investing.com - Investing.com South Africa
BFI Co sells Phibro Animal Health (PAHC) stock worth $1.19 million - Investing.com Australia
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 10,560 Shares of Stock - MarketBeat
Phibro Animal Health (PAHC) CEO-linked BFI Co. sells 22,880 shares in Rule 10b5-1 trades - Stock Titan
Phibro Animal Health says Daniel Bendheim to assume CEO role in July - MSN
Volatility Watch: Is Phibro Animal Health Corporation gaining market shareOil Prices & Weekly Setup with ROI Potential - baoquankhu1.vn
Phibro Animal Health (PAHC) director Bendheim sells $258,244 in shares By Investing.com - Investing.com South Africa
Phibro Animal Health (PAHC) director Bendheim sells $258,244 in shares - Investing.com
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 5,280 Shares - MarketBeat
BFI Co. tied to Phibro Animal Health (PAHC) converts and sells shares - Stock Titan
A Look At Phibro Animal Health (PAHC) Valuation After Recent Share Price Gains - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Upgraded at Zacks Research - Defense World
Multiple resale transactions by affiliate reported for Phibro Animal Health (PAHC) - Stock Titan
Zacks Research Upgrades Phibro Animal Health (NASDAQ:PAHC) to Strong-Buy - MarketBeat
Is PAHC Stock a Solid Investment Opportunity Right Now? - Yahoo Finance
Best Value Stocks to Buy for March 12th - Yahoo Finance
Looking for earnings beat? Buy these 4 top-ranked stocks - MSN
EPS Watch: Will Phibro Animal Health Corporation benefit from AI trends2026 Momentum Check & Verified Swing Trading Watchlists - baoquankhu1.vn
Is Community Health Systems Attractive Despite Its Heavy Debt Load? - TradingView
Is It Too Late To Consider Phibro Animal Health (PAHC) After 1-Year Share Price Surge? - simplywall.st
How risky is Phibro Animal Health Corporation stock nowJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - Naître et grandir
Phibro Animal Health Corporation $PAHC Shares Sold by Vanguard Group Inc. - MarketBeat
How The Investment Story Is Shifting For Phibro Animal Health (PAHC) After Fresh Analyst Targets - Yahoo Finance
Here's Why Ensign Group Shares Are Attracting Investors Now - TradingView
How To YieldBoost PAHC To 15.4% Using Options - Nasdaq
Ex-Dividend Reminder: Phibro Animal Health, Pjt Partners and Equitable Holdings - Nasdaq
Phibro Animal Health Raises Guidance at BofA Conference as Zoetis MFA Integration Advances - Yahoo Finance
Phibro Animal Health's CEO Sold Over 14,000 Shares. Is the Stock a Buy or Sell? - Yahoo Finance
Zacks.com featured highlights include Crocs, LATAM Airlines, Arrow Electronics and Phibro Animal Health - Yahoo Finance
Phibro Animal Health (PAHC) director sells $1.1 million in stock By Investing.com - Investing.com South Africa
Phibro Animal Health (PAHC) director sells $1.1 million in stock - Investing.com Nigeria
Phibro Animal Health (PAHC) CEO-linked LLC sells 21,120 shares - Stock Titan
Phibro at BofA Securities Summit: Strategic Growth and Integration - Investing.com
Jack Bendheim Sells 7,040 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock - Defense World
Phibro Animal Health Corp. Achieves 124.29% Return, Emerging as a Multibagger in Pharmaceuticals Sector - Markets Mojo
Insider entity BFI Co. LLC trims Phibro Animal Health (PAHC) stake - Stock Titan
What Phibro Animal Health (PAHC)'s Stronger Q2 and Maturing Feed Additive Portfolio Mean For Shareholders - Yahoo Finance
PAHC Technical Analysis & ETF Price Forecast - Intellectia AI
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - Yahoo Finance
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - The Motley Fool
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Best Momentum Stocks to Buy for February 20th - Yahoo Finance
Best Value Stocks to Buy for February 20th - Yahoo Finance
Assessing Phibro Animal Health (PAHC) Valuation After Strong Share Price Momentum - Yahoo Finance
Zacks Research Issues Positive Forecast for PAHC Earnings - MarketBeat
Weekly Earnings: Is Phibro Animal Health Corporation forming a breakout patternBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Phibro Animal Health Corp Stock (PAHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):